Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:48 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Quick Heal Technologies Ltd operates in the IT consulting and software sector, primarily focusing on cybersecurity solutions. As of now, the stock price is ₹282, with a market capitalization of ₹1,528 Cr. The company has experienced fluctuating revenue, as highlighted by its quarterly sales figures. For instance, sales dipped significantly to ₹49.28 Cr in March 2023, recovering slightly to ₹51.44 Cr in June 2023, but the overall trend appears inconsistent. The sales for the trailing twelve months stood at ₹266 Cr, a stark contrast to the ₹342 Cr recorded in March 2022. This decline raises questions about the company’s market position and ability to adapt to changing cybersecurity demands. Given the current competitive landscape, Quick Heal may need to reassess its strategies to regain momentum and capitalize on the growing cybersecurity market.
Profitability and Efficiency Metrics
The profitability metrics for Quick Heal paint a rather concerning picture. The operating profit margin (OPM) has been negative for several quarters, hitting a low of -32.81% in March 2023, and currently standing at -17% as of June 2025. This consistent downturn in profitability is alarming, especially as the company reported a net profit of ₹-4 Cr for the latest fiscal year. The interest coverage ratio, though notably high at 64.45x, suggests that while the company is not burdened by debt—having recorded zero borrowings—it may still struggle to convert sales into profit. Moreover, the return on equity (ROE) at just 0.63% indicates that shareholder returns are minimal, which could affect investor sentiment in the long run. The company must focus on improving cost management and operational efficiencies to turn these figures around.
Balance Sheet Strength and Financial Ratios
Quick Heal’s balance sheet shows a solid foundation with no borrowings, which is a commendable strength. The total reserves stand at ₹392 Cr, providing a buffer against operational challenges. However, the current ratio of 4.71x indicates that while the company has sufficient current assets to cover liabilities, it also reflects a potential inefficiency in asset utilization. The price-to-book value ratio of 3.51x suggests that the stock may be trading at a premium compared to its book value, which can be a red flag for investors seeking value. Additionally, the enterprise value (EV) of ₹1,527 Cr and its EV/EBITDA ratio of 107.72x signal that the market may have high expectations for future profitability that the company has yet to meet. Overall, while Quick Heal’s balance sheet appears robust, its financial ratios indicate that the market is not fully convinced of its growth potential.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Quick Heal reveals a strong promoter presence at 71.63%, which can instill confidence among retail investors. However, foreign institutional investors (FIIs) hold a mere 0.50%, raising concerns about external confidence in the company. Domestic institutional investors (DIIs) have a slightly better stake at 2.33%, but overall, the public holding is significant at 25.53%. This distribution suggests that while the promoters are committed, the lack of interest from institutional investors could indicate skepticism regarding the company’s growth trajectory. The number of shareholders has declined from 66,028 in December 2022 to 55,910, reflecting a potential exit of retail investors. This trend could be a warning sign for potential investors to scrutinize the company’s operational strategies and profitability metrics more closely before making investment decisions.
Outlook, Risks, and Final Insight
Looking ahead, Quick Heal Technologies faces a mixed bag of opportunities and risks. The rising demand for cybersecurity solutions presents a significant growth opportunity, especially as cyber threats become increasingly sophisticated. However, the company’s historical performance raises red flags. The erratic revenue trends and persistent losses suggest that Quick Heal must execute a robust turnaround strategy to regain investor confidence. Additionally, reliance on the domestic market poses risks, as any economic downturn could further impact sales. Investors should weigh these factors carefully, considering both the potential for recovery and the inherent risks. A prudent approach would involve closely monitoring the company’s upcoming strategic initiatives, operational improvements, and market conditions before committing to an investment. In conclusion, while Quick Heal has strengths in its balance sheet and market potential, the path to recovery appears fraught with challenges that require vigilant observation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 49.2 Cr. | 15.6 | 15.6/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 151 Cr. | 140 | 194/99.8 | 23.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 25.6 Cr. | 200 | 310/140 | 18.3 | 26.7 | 0.50 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.28 Cr. | 1.08 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,491.18 Cr | 558.12 | 86.50 | 123.78 | 0.54% | 14.89% | 20.93% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 61.08 | 100.94 | 66.80 | 49.28 | 51.44 | 78.36 | 81.92 | 80.03 | 70.29 | 73.49 | 70.61 | 65.14 | 57.23 |
| Expenses | 60.03 | 72.56 | 78.17 | 65.45 | 66.52 | 67.39 | 70.30 | 69.99 | 67.70 | 70.42 | 74.38 | 73.62 | 66.96 |
| Operating Profit | 1.05 | 28.38 | -11.37 | -16.17 | -15.08 | 10.97 | 11.62 | 10.04 | 2.59 | 3.07 | -3.77 | -8.48 | -9.73 |
| OPM % | 1.72% | 28.12% | -17.02% | -32.81% | -29.32% | 14.00% | 14.18% | 12.55% | 3.68% | 4.18% | -5.34% | -13.02% | -17.00% |
| Other Income | 3.20 | 5.40 | 3.47 | 10.06 | 4.73 | 5.69 | 4.15 | 6.82 | 5.06 | 5.20 | 4.91 | 5.60 | 5.75 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 |
| Depreciation | 3.95 | 4.14 | 4.17 | 3.73 | 2.93 | 3.25 | 3.24 | 3.18 | 2.79 | 3.15 | 3.39 | 3.63 | 2.96 |
| Profit before tax | 0.30 | 29.64 | -12.07 | -9.84 | -13.28 | 13.41 | 12.53 | 13.55 | 4.81 | 5.07 | -2.31 | -6.57 | -7.00 |
| Tax % | 40.00% | 25.24% | -23.03% | -32.52% | -3.92% | 3.80% | 19.71% | -3.62% | 16.22% | 18.15% | -104.76% | -50.53% | -21.29% |
| Net Profit | 0.18 | 22.16 | -9.29 | -6.64 | -12.76 | 12.90 | 10.06 | 14.04 | 4.03 | 4.15 | 0.11 | -3.25 | -5.51 |
| EPS in Rs | 0.03 | 3.82 | -1.75 | -1.25 | -2.40 | 2.43 | 1.89 | 2.62 | 0.75 | 0.77 | 0.02 | -0.60 | -1.02 |
Last Updated: August 20, 2025, 4:55 am
Below is a detailed analysis of the quarterly data for Quick Heal Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 57.23 Cr.. The value appears to be declining and may need further review. It has decreased from 65.14 Cr. (Mar 2025) to 57.23 Cr., marking a decrease of 7.91 Cr..
- For Expenses, as of Jun 2025, the value is 66.96 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 73.62 Cr. (Mar 2025) to 66.96 Cr., marking a decrease of 6.66 Cr..
- For Operating Profit, as of Jun 2025, the value is -9.73 Cr.. The value appears to be declining and may need further review. It has decreased from -8.48 Cr. (Mar 2025) to -9.73 Cr., marking a decrease of 1.25 Cr..
- For OPM %, as of Jun 2025, the value is -17.00%. The value appears to be declining and may need further review. It has decreased from -13.02% (Mar 2025) to -17.00%, marking a decrease of 3.98%.
- For Other Income, as of Jun 2025, the value is 5.75 Cr.. The value appears strong and on an upward trend. It has increased from 5.60 Cr. (Mar 2025) to 5.75 Cr., marking an increase of 0.15 Cr..
- For Interest, as of Jun 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For Depreciation, as of Jun 2025, the value is 2.96 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.63 Cr. (Mar 2025) to 2.96 Cr., marking a decrease of 0.67 Cr..
- For Profit before tax, as of Jun 2025, the value is -7.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.57 Cr. (Mar 2025) to -7.00 Cr., marking a decrease of 0.43 Cr..
- For Tax %, as of Jun 2025, the value is -21.29%. The value appears to be increasing, which may not be favorable. It has increased from -50.53% (Mar 2025) to -21.29%, marking an increase of 29.24%.
- For Net Profit, as of Jun 2025, the value is -5.51 Cr.. The value appears to be declining and may need further review. It has decreased from -3.25 Cr. (Mar 2025) to -5.51 Cr., marking a decrease of 2.26 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.02. The value appears to be declining and may need further review. It has decreased from -0.60 (Mar 2025) to -1.02, marking a decrease of 0.42.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:13 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 243 | 286 | 302 | 300 | 318 | 315 | 286 | 333 | 342 | 278 | 292 | 280 | 266 |
| Expenses | 157 | 194 | 200 | 210 | 198 | 187 | 195 | 192 | 235 | 276 | 274 | 286 | 285 |
| Operating Profit | 85 | 92 | 102 | 90 | 120 | 128 | 92 | 141 | 107 | 2 | 18 | -7 | -19 |
| OPM % | 35% | 32% | 34% | 30% | 38% | 41% | 32% | 42% | 31% | 1% | 6% | -2% | -7% |
| Other Income | 11 | 8 | 10 | 25 | 30 | 33 | 31 | 24 | 19 | 22 | 21 | 21 | 21 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 20 | 24 | 31 | 27 | 24 | 22 | 19 | 17 | 16 | 13 | 13 | 13 |
| Profit before tax | 86 | 80 | 88 | 84 | 123 | 137 | 101 | 146 | 109 | 8 | 26 | 1 | -11 |
| Tax % | 32% | 33% | 34% | 37% | 33% | 33% | 27% | 27% | 23% | 20% | 8% | -404% | |
| Net Profit | 58 | 54 | 58 | 53 | 83 | 92 | 74 | 107 | 83 | 6 | 24 | 5 | -4 |
| EPS in Rs | 9.56 | 8.81 | 8.27 | 7.59 | 11.79 | 13.01 | 11.59 | 16.66 | 14.34 | 1.21 | 4.53 | 0.93 | -0.83 |
| Dividend Payout % | 78% | 85% | 30% | 33% | 25% | 15% | 35% | 24% | 31% | 207% | 66% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.90% | 7.41% | -8.62% | 56.60% | 10.84% | -19.57% | 44.59% | -22.43% | -92.77% | 300.00% | -79.17% |
| Change in YoY Net Profit Growth (%) | 0.00% | 14.30% | -16.03% | 65.22% | -45.76% | -30.41% | 64.16% | -67.02% | -70.34% | 392.77% | -379.17% |
Quick Heal Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -41% |
| 3 Years: | -60% |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 11% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 2% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 12:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 61 | 61 | 70 | 70 | 70 | 71 | 64 | 64 | 58 | 53 | 54 | 54 | 54 |
| Reserves | 271 | 270 | 559 | 592 | 653 | 719 | 580 | 687 | 570 | 367 | 383 | 387 | 392 |
| Borrowings | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 |
| Other Liabilities | 47 | 97 | 88 | 72 | 57 | 63 | 52 | 75 | 88 | 74 | 76 | 83 | 99 |
| Total Liabilities | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
| Fixed Assets | 82 | 111 | 142 | 185 | 173 | 165 | 158 | 146 | 137 | 124 | 117 | 119 | 117 |
| CWIP | 55 | 74 | 55 | 14 | 14 | 11 | 3 | 2 | -0 | 0 | 3 | 0 | 9 |
| Investments | 131 | 130 | 115 | 182 | 306 | 390 | 310 | 416 | 318 | 198 | 190 | 179 | 185 |
| Other Assets | 111 | 113 | 405 | 353 | 287 | 288 | 225 | 263 | 261 | 171 | 203 | 226 | 234 |
| Total Assets | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
Below is a detailed analysis of the balance sheet data for Quick Heal Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 54.00 Cr..
- For Reserves, as of Sep 2025, the value is 392.00 Cr.. The value appears strong and on an upward trend. It has increased from 387.00 Cr. (Mar 2025) to 392.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 16.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 117.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 185.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 545.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (392.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 85.00 | 92.00 | 102.00 | 90.00 | 120.00 | 128.00 | 92.00 | 141.00 | 107.00 | 2.00 | 18.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104 | 83 | 112 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Inventory Days | 181 | 144 | ||||||||||
| Days Payable | 864 | 1,103 | ||||||||||
| Cash Conversion Cycle | 104 | -600 | -847 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Working Capital Days | 52 | -23 | 29 | 49 | 70 | 92 | 94 | 98 | 102 | 83 | 88 | 354 |
| ROCE % | 27% | 24% | 18% | 14% | 18% | 18% | 14% | 21% | 15% | 0% | 6% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Digital India Fund | 425,000 | 0.11 | 13.49 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.94 | 4.56 | 1.14 | 14.01 | 16.66 |
| Diluted EPS (Rs.) | 0.91 | 4.48 | 1.14 | 13.94 | 16.65 |
| Cash EPS (Rs.) | 3.33 | 6.88 | 4.22 | 17.34 | 19.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Revenue From Operations / Share (Rs.) | 51.76 | 54.52 | 52.40 | 58.94 | 51.87 |
| PBDIT / Share (Rs.) | 2.63 | 7.28 | 4.52 | 21.73 | 25.80 |
| PBIT / Share (Rs.) | 0.22 | 4.92 | 1.51 | 18.73 | 22.76 |
| PBT / Share (Rs.) | 0.18 | 4.90 | 1.51 | 18.73 | 22.76 |
| Net Profit / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| NP After MI And SOA / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| PBDIT Margin (%) | 5.07 | 13.34 | 8.63 | 36.87 | 49.73 |
| PBIT Margin (%) | 0.43 | 9.02 | 2.88 | 31.78 | 43.87 |
| PBT Margin (%) | 0.35 | 8.98 | 2.88 | 31.78 | 43.87 |
| Net Profit Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| NP After MI And SOA Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| Return on Networth / Equity (%) | 1.14 | 5.54 | 1.52 | 13.25 | 14.23 |
| Return on Capital Employeed (%) | 0.27 | 5.99 | 1.90 | 17.25 | 19.41 |
| Return On Assets (%) | 0.95 | 4.72 | 1.29 | 11.62 | 12.94 |
| Asset Turnover Ratio (%) | 0.53 | 0.58 | 0.46 | 0.44 | 0.43 |
| Current Ratio (X) | 4.71 | 4.96 | 4.50 | 6.20 | 8.53 |
| Quick Ratio (X) | 4.69 | 4.93 | 4.43 | 6.15 | 8.49 |
| Inventory Turnover Ratio (X) | 2.43 | 0.11 | 0.23 | 0.24 | 0.21 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 54.74 | 407.96 | 27.85 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 36.02 | 116.61 | 23.03 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 45.26 | -307.96 | 72.15 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 63.98 | -16.61 | 76.97 | 0.00 |
| Interest Coverage Ratio (X) | 64.45 | 299.54 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 23.91 | 187.46 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1527.48 | 2480.96 | 695.04 | 966.92 | 1113.79 |
| EV / Net Operating Revenue (X) | 5.46 | 8.50 | 2.50 | 2.83 | 3.34 |
| EV / EBITDA (X) | 107.72 | 63.71 | 28.95 | 7.67 | 6.72 |
| MarketCap / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| Retention Ratios (%) | 0.00 | 45.25 | -307.96 | 72.14 | 0.00 |
| Price / BV (X) | 3.51 | 5.76 | 1.68 | 1.64 | 1.59 |
| Price / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| EarningsYield | 0.00 | 0.01 | 0.01 | 0.08 | 0.08 |
After reviewing the key financial ratios for Quick Heal Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 5. It has decreased from 4.56 (Mar 24) to 0.94, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 24) to 0.91, marking a decrease of 3.57.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.33. This value is within the healthy range. It has decreased from 6.88 (Mar 24) to 3.33, marking a decrease of 3.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.76. It has decreased from 54.52 (Mar 24) to 51.76, marking a decrease of 2.76.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 7.28 (Mar 24) to 2.63, marking a decrease of 4.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 0.22, marking a decrease of 4.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.18. This value is within the healthy range. It has decreased from 4.90 (Mar 24) to 0.18, marking a decrease of 4.72.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For PBDIT Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 10. It has decreased from 13.34 (Mar 24) to 5.07, marking a decrease of 8.27.
- For PBIT Margin (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 10. It has decreased from 9.02 (Mar 24) to 0.43, marking a decrease of 8.59.
- For PBT Margin (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 10. It has decreased from 8.98 (Mar 24) to 0.35, marking a decrease of 8.63.
- For Net Profit Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 5. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 8. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 5.54 (Mar 24) to 1.14, marking a decrease of 4.40.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 10. It has decreased from 5.99 (Mar 24) to 0.27, marking a decrease of 5.72.
- For Return On Assets (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 4.72 (Mar 24) to 0.95, marking a decrease of 3.77.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has decreased from 0.58 (Mar 24) to 0.53, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 4.71. This value exceeds the healthy maximum of 3. It has decreased from 4.96 (Mar 24) to 4.71, marking a decrease of 0.25.
- For Quick Ratio (X), as of Mar 25, the value is 4.69. This value exceeds the healthy maximum of 2. It has decreased from 4.93 (Mar 24) to 4.69, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 4. It has increased from 0.11 (Mar 24) to 2.43, marking an increase of 2.32.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 54.74 (Mar 24) to 0.00, marking a decrease of 54.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 36.02 (Mar 24) to 0.00, marking a decrease of 36.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 45.26 (Mar 24) to 0.00, marking a decrease of 45.26.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 63.98 (Mar 24) to 0.00, marking a decrease of 63.98.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 64.45. This value is within the healthy range. It has decreased from 299.54 (Mar 24) to 64.45, marking a decrease of 235.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.91. This value is within the healthy range. It has decreased from 187.46 (Mar 24) to 23.91, marking a decrease of 163.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,527.48. It has decreased from 2,480.96 (Mar 24) to 1,527.48, marking a decrease of 953.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has decreased from 8.50 (Mar 24) to 5.46, marking a decrease of 3.04.
- For EV / EBITDA (X), as of Mar 25, the value is 107.72. This value exceeds the healthy maximum of 15. It has increased from 63.71 (Mar 24) to 107.72, marking an increase of 44.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 45.25 (Mar 24) to 0.00, marking a decrease of 45.25.
- For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has decreased from 5.76 (Mar 24) to 3.51, marking a decrease of 2.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Quick Heal Technologies Ltd:
- Net Profit Margin: 1.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.27% (Industry Average ROCE: 14.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 20.93%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 86.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Solitaire Business Hub, Pune Maharashtra 411014 | cs@quickheal.co.in http://www.quickheal.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kailash Sahebrao Katkar | Chairman & Managing Director |
| Dr. Sanjay Sahebrao Katkar | Joint Managing Director |
| Mr. Shailesh Lakhani | Non Executive Director |
| Mr. Amitabha Mukhopadhyay | Independent Director |
| Air M'shal (Retd.) Bhushan Nilkanth Gokhale | Independent Director |
| Ms. Apurva Pradeep Joshi | Independent Director |
| Mr. Richard Stiennon | Independent Director |
| Mr. Kamal Kumar Agarwal | Independent Director |
FAQ
What is the intrinsic value of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd's intrinsic value (as of 13 December 2025) is 6.36 which is 97.74% lower the current market price of 281.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,524 Cr. market cap, FY2025-2026 high/low of 707/245, reserves of ₹392 Cr, and liabilities of 545 Cr.
What is the Market Cap of Quick Heal Technologies Ltd?
The Market Cap of Quick Heal Technologies Ltd is 1,524 Cr..
What is the current Stock Price of Quick Heal Technologies Ltd as on 13 December 2025?
The current stock price of Quick Heal Technologies Ltd as on 13 December 2025 is 281.
What is the High / Low of Quick Heal Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Quick Heal Technologies Ltd stocks is 707/245.
What is the Stock P/E of Quick Heal Technologies Ltd?
The Stock P/E of Quick Heal Technologies Ltd is .
What is the Book Value of Quick Heal Technologies Ltd?
The Book Value of Quick Heal Technologies Ltd is 82.5.
What is the Dividend Yield of Quick Heal Technologies Ltd?
The Dividend Yield of Quick Heal Technologies Ltd is 0.00 %.
What is the ROCE of Quick Heal Technologies Ltd?
The ROCE of Quick Heal Technologies Ltd is 0.24 %.
What is the ROE of Quick Heal Technologies Ltd?
The ROE of Quick Heal Technologies Ltd is 0.63 %.
What is the Face Value of Quick Heal Technologies Ltd?
The Face Value of Quick Heal Technologies Ltd is 10.0.